Organoids with a Type 1 Collagen Scaffold to Model Bacterial Cancer Therapy.

Area of Science:

• Oncology
• Microbiology
• Biotechnology

Background:

• Bacterial cancer therapy (BCT) is a promising approach for solid tumors.
• Understanding bacterial colonization and host response in tumors is crucial for BCT advancement.
• Current models lack efficient bacterial colonization and detailed visualization.

Purpose of the Study:

• To develop a novel organoid model for studying bacterial colonization in tumors.
• To compare the efficacy of type I collagen versus Matrigel as an extracellular matrix for BCT.
• To establish a platform for personalized BCT development.

Main Methods:

• Development of organoids using a type I collagen matrix scaffold.
• Comparison of bacterial infection efficiency and growth in type I collagen versus Matrigel.
• Utilizing patient-derived organoids for personalized treatment modeling.

Main Results:

• Type I collagen significantly enhanced initial bacterial infection efficiency (>5-fold) compared to Matrigel.
• Bacterial cell numbers increased over 10-fold within 4 days in type I collagen organoids.
• The organoid model allows visualization of bacterial chemoattraction, invasion, and colonization.

Conclusions:

• Type I collagen organoids provide a superior model for BCT research.
• This platform facilitates the optimization of bacterial colonization and treatment strategies.
• Patient-derived organoids pave the way for personalized BCT applications.